JPMORGAN CHASE & CO - FULCRUM THERAPEUTICS INC ownership

FULCRUM THERAPEUTICS INC's ticker is FULC and the CUSIP is 359616109. A total of 107 filers reported holding FULCRUM THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.06 and the average weighting 0.3%.

Quarter-by-quarter ownership
JPMORGAN CHASE & CO ownership history of FULCRUM THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$48,392
+1016.1%
10,899
+729.5%
0.00%
Q2 2023$4,336
-99.2%
1,314
-99.3%
0.00%
Q1 2023$543,000
+40271.7%
190,269
+3.0%
0.00%
Q4 2022$1,345
-99.9%
184,686
-5.8%
0.00%
Q3 2022$1,585,000
+63.2%
195,960
-1.1%
0.00%
Q2 2022$971,000
-79.5%
198,115
-1.1%
0.00%
-100.0%
Q1 2022$4,739,000
+32.0%
200,386
-1.2%
0.00%
Q4 2021$3,589,000
-26.8%
202,873
+16.8%
0.00%
-100.0%
Q3 2021$4,901,000
+153.4%
173,727
-5.9%
0.00%
Q2 2021$1,934,000
-38.2%
184,572
-30.5%
0.00%
Q1 2021$3,127,000
+571.0%
265,505
+567.1%
0.00%
Q4 2020$466,000
+1036.6%
39,800
+646.0%
0.00%
Q3 2020$41,000
-52.9%
5,335
+12.3%
0.00%
Q2 2020$87,000
-65.6%
4,750
-77.6%
0.00%
Q1 2020$253,000
+155.6%
21,176
+258.2%
0.00%
Q4 2019$99,000
+890.0%
5,912
+297.3%
0.00%
Q3 2019$10,0001,4880.00%
Other shareholders
FULCRUM THERAPEUTICS INC shareholders Q3 2022
NameSharesValueWeighting ↓
TRV GP III, LLC 3,962,202$19,415,0007.94%
TRV GP IV, LLC 2,343,154$11,481,0007.55%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 949$193,741,0002.02%
Logos Global Management LP 1,950,000$9,555,0001.75%
COWEN AND COMPANY, LLC 2,385,885$11,691,0001.13%
SUVRETTA CAPITAL MANAGEMENT, LLC 3,355,624$16,443,0000.62%
ACUTA CAPITAL PARTNERS, LLC 200,000$980,0000.55%
RTW INVESTMENTS, LP 3,961,194$19,410,0000.50%
Parkman Healthcare Partners LLC 262,689$1,287,0000.47%
Deep Track Capital, LP 1,000,000$4,900,0000.32%
View complete list of FULCRUM THERAPEUTICS INC shareholders